ArticleGates open research2025

CYP2D6 Pharmacogenetics in Nigerian Sickle Cell Disease: Phase 1 of Implementing Pharmacogenomics Testing for Effective Care and Treatment in Africa (iPROTECTA) program.

Babatunde Adeagbo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.